Vesalio’s NATURE trial of enVast achieves primary endpoint
The prospective, multi-centre study enrolled 154 patients at 11 centres.
News
Kardium secures $22.5m funding for pulsed field system manufacturing
Philips and Imricor introduce MR lab solution for cardiac interventions
Paradromics gets FDA nod for broader BCI device compatibility
PENTAX broadens MAGENTIQ EYE partnership for global AI colonoscopy
FDA approves Abbott’s Libre Duo 10 Day dual glucose-ketone monitor
Axoft launches Fleuron WISE polymer for advanced biological imaging
Medical Guardian unveils Guardian Flex wearable for older adults
